| |
Article Title |
Author(s) |
Pages |
|
|
|
Editorial Board
|
|
i
|
|
|
|
Management of bacterial infections in cirrhosis
Summary: Bacterial infections are very frequent in advanced cirrhosis and become the first cause of death of these patients. Despite numerous experimental data and significant advances in the understa...
|
Javier Fernández,
Thierry Gustot
|
S1-S12
|
|
|
|
Management of critically-ill cirrhotic patients
Summary: Cirrhotic patients are prone to develop life-threatening complications that require emergency care and ICU admission. They can present specific decompensations related to cirrhosis such as va...
|
Pere Ginès,
Javier Fernández,
François Durand,
Faouzi Saliba
|
S13-S24
|
|
|
|
Management of hepatic vascular diseases
Summary: Primary damage to hepatic vessels is rare. (i) Hepatic arterial disorders, related mostly to iatrogenic injury and occasionally to systemic diseases, lead to ischemic cholangiopathy. (ii) Hep...
|
Aurélie Plessier,
Pierre-Emmanuel Rautou,
Dominique-Charles Valla
|
S25-S38
|
|
|
|
Management of alcoholic hepatitis
|
Philippe Mathurin,
Michael R. Lucey
|
S39-S45
|
|
|
|
Managing systemic symptoms in chronic liver disease
Summary: Improved medical management and the changing disease demographic mean that the majority of patients with chronic liver disease are living with the disease rather than dying from it. Historica...
|
Julia L. Newton,
David E.J. Jones
|
S46-S55
|
|
|
|
The interaction of metabolic factors with HCV infection: Does it matter?
Summary: Given the pandemic spread of the hepatitis C virus (HCV) infection and the metabolic syndrome (MS), the burden of their interaction is a major public health issue, bound to increase in the ne...
|
Elisabetta Bugianesi,
Federico Salamone,
Francesco Negro
|
S56-S65
|
|
|
|
Anti-fibrotic therapy: Lost in translation?
Summary: While preclinical development of potential anti-fibrotics is far advanced, with numerous pharmacological targets and promising agents, almost none has entered clinical validation. Reasons are...
|
Detlef Schuppan,
Massimo Pinzani
|
S66-S74
|
|
|
|
Management of HCC
Summary: Hepatocellular carcinoma (HCC) is a highly prevalent and lethal neoplasia, the management of which has significantly improved during the last few years. A better knowledge of the natural hist...
|
Carlos Rodríguez de Lope,
Silvia Tremosini,
Alejandro Forner,
María Reig,
Jordi Bruix
et al.
|
S75-S87
|
|
|
|
Antiviral strategies in hepatitis C virus infection
Summary: Resolution of the three-dimensional structures of several hepatitis C virus (HCV) proteins, together with the development of replicative cell culture systems, has led to the identification of...
|
Christoph Sarrazin,
Christophe Hézode,
Stefan Zeuzem,
Jean-Michel Pawlotsky
|
S88-S100
|
|
|
|
Trends in liver transplantation 2011
Summary: This review will highlight some of the important recent trends in liver transplantation. When possible, we will compare and contrast these trends across various regions of the world, in an ef...
|
Patrizia Burra,
Richard Freeman
|
S101-S111
|
|
|
|
Management of treatment failure in chronic hepatitis B
Summary: Antiviral therapy of chronic hepatitis B remains a clinical challenge. The primary goal of therapy is to prevent liver disease progression. Because of the mechanism of viral persistence in in...
|
Fabien Zoulim,
Stephen Locarnini
|
S112-S122
|
|
